RIL
TGTX icon

Rothschild Investment LLC’s TG Therapeutics TGTX Stock Holding History

Rothschild Investment LLC’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.9K Buy
507
+74
+17% +$3.03K ﹤0.01% 1436
2026
Q1 		$14.4K Buy
433
+144
+50% +$4.29K ﹤0.01% 1545
2025
Q4 		$8.62K Buy
289
+24
+9% +$784 ﹤0.01% 1627
2025
Q3 		$9.57K Sell
265
-15
-5% -$494 ﹤0.01% 1462
2025
Q2 		$10.1K Buy
280
+20
+8% +$745 ﹤0.01% 1214
2025
Q1 		$10.3K Buy
260
+80
+44% +$2.69K ﹤0.01% 1168
2024
Q4 		$5.42K Buy
180
+30
+20% +$861 ﹤0.01% 1323
2024
Q3 		$3.51K Buy
150
+70
+88% +$1.53K ﹤0.01% 1431
2024
Q2 		$1.42K Buy
80
+70
+700% +$1.12K ﹤0.01% 1504
2024
Q1 		$152 Buy
+10
New +$159 ﹤0.01% 1896

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Rothschild Investment LLC's TGTX Position: Q2 2026 in Review

Rothschild Investment LLC increased its TG Therapeutics (TGTX) stake by 17% in Q2 2026, buying an estimated $3.03K and bringing the position to 507 shares worth $27.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1436.

Rothschild Investment LLC first reported a position in TGTX in Q1 2024 and has held it in 10 quarters since. 430 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Rothschild Investment LLC held 507 shares of TG Therapeutics worth $27.9K as of Q2 2026.
  • Rothschild Investment LLC bought 74 TG Therapeutics shares in Q2 2026, an estimated $3.03K.
  • TG Therapeutics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #1436 holding.
  • Rothschild Investment LLC first reported a position in TG Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • 430 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.